791 Treatment patterns and real-world clinical outcomes of first-line anti-PD(L)1-based combination therapy among patients with non-squamous metastatic non-small cell lung cancer in Japan

Abstract

BackgroundAnti-PD(L)1-based combination therapy is the standard of care as first-line (1L) treatment for patients with non-squamous (NSQ) metastatic non-small cell lung cancer (mNSCLC) without driver alterations. This study aimed to...